Japan Computed Tomography Market Size and Share

Japan Computed Tomography Market (2025 - 2030)
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
View Global Report

Japan Computed Tomography Market Analysis by Mordor Intelligence

The Japan computed tomography market size stands at USD 555.1 million in 2025 and is forecast to attain USD 799.5 million by 2030, advancing at a 7.03% CAGR. The expansion is fueled by the country’s super-aged demographic profile, steady oncology screening volumes, and the rollout of photon-counting systems that permit dose-efficient spectral imaging. Vendors capitalize on reimbursement incentives for AI-enabled low-dose protocols and on disaster-preparedness budgets that underwrite mobile fleets. The convergence of these factors shelters pricing power even as scan-fee revisions trend downward. Competitive dynamics remain moderate because four multinational manufacturers control most installed bases, yet white-space opportunities persist in portable architectures and AI retrofit kits that augment legacy scanners without full-system replacement.

Key Report Takeaways

  • By technology, Mid-End 64-slice systems accounted for 46.16% of the Japan computed tomography market share in 2024, while Above 128-slice platforms are projected to post a 6.34% CAGR through 2030.
  • By product type, Stationary scanners commanded 91.79% revenue in 2024; Portable scanners are forecast to expand at a 6.94% CAGR to 2030.
  • By application, Oncology held 34.18% of the Japan computed tomography market size in 2024, and Cardiology is tracking the fastest CAGR at 6.71% through 2030.
  • By end-user, Hospitals led with a 58.15% share in 2024, whereas Private Hospitals are slated to deliver a 6.34% CAGR through 2030

Segment Analysis

By Technology: Mid-Slice Platforms Anchor Clinical Volume

Mid-End 64-slice scanners retained 46.16% of 2024 revenue because they satisfy bread-and-butter oncology and trauma protocols at manageable ownership costs. The Japan computed tomography market size for this tier is projected to expand at 5.2% through 2030 as iterative reconstruction keeps them dose-competitive. High-slice (>128) installations, while only 18% of unit shipments in 2024, capture the prestige segment and are forecast to add USD 97 million by 2030, reflecting a 6.34% CAGR tied to photon-counting launches. Vendor roadmaps indicate detector-module backward-compatibility that lets facilities upgrade piecemeal, elongating replacement cycles yet boosting software revenue streams.

Clinical consensus increasingly favors spectral capabilities, nudging even mid-slice buyers to consider dual-energy add-ons. Canon’s 1024-matrix reconstruction upgrade delivered 0.4 mm airway visualization on existing 320-row Aquilion installations, blurring performance gaps with high-slice peers. Consequently, manufacturers package AI-based metal-artifact reduction and calcium-scoring automation as subscription layers, reinforcing multi-year annuity models across the Japan computed tomography market.

Japan Computed Tomography Market: Market Share by Technology
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By Product Type: Stationary Dominance, Portable Momentum

Stationary scanners accounted for 91.79% of units in 2024, underscoring entrenched hospital work-flows and lead-lining requirements. Their throughput advantage bolsters ROI in facilities exceeding 40 patients per day, explaining continued procurement despite space constraints. Portable scanners, though a modest 8.21% slice, are advancing at a 6.94% CAGR on the back of disaster-resilience legislation that subsidizes two mobile units per prefecture. Field hospitals also deploy compact 32-row variants for neuro triage, dovetailing with population-aging policies that emphasize home-and-community care.

Technological cross-pollination lifts both segments. Photon-counting detector miniaturization allows vendors to ship battery-powered units without compromising spectral resolution, broadening clinical eligibility beyond head CT into thoracic and vascular indications. The shift accelerates revenue diversification across the Japan computed tomography market.

By Application: Oncology Leads, Cardiology Accelerates

Oncology generated 34.18% of 2024 revenue after lung-cancer screening volumes rebounded to pre-pandemic levels. Program expansion in Kanagawa and Hokkaido prefectures will amplify scan counts by an estimated 11% over 2025-2027. Cardiology remains the fastest-gaining application, logging a 6.71% CAGR as expanded coronary CT angiography guidelines recommend non-invasive imaging before catheterization in intermediate-risk cohorts. The Japan computed tomography market size for cardiac exams is forecast to reach USD 152 million in 2030, up from USD 110 million in 2024.

Neurology scans hold steady due to stroke-code adherence, while vascular and musculoskeletal niches see incremental lift from dose-efficient spectral scans that cut contrast volumes by 25%. AI triage software that flags pulmonary embolism and intracranial bleeds keeps radiologist workloads manageable, sustaining demand even amid staffing shortages.

By End-User: Hospital Backbone, Private-Sector Upshift

Hospitals controlled 58.15% of 2024 spending, reflecting their gatekeeper role in universal coverage. Public institutions focus on mid-slice replacements, whereas private hospitals pursue differentiation via photon-counting systems and AI co-pilots, supporting a 6.34% CAGR. Diagnostic imaging centers are expanding in suburbs where aging populations prefer outpatient convenience, translating to tailored service contracts that bundle scanner, PACS, and cloud analytics.

Academic institutes, though <5% of unit volume, punch above their weight in innovation adoption, serving as reference sites that catalyze nationwide rollouts. Veterinary and dental clinics remain niche but profitable add-ons, often buying compact cone-beam units assembled locally.

Japan Computed Tomography Market: Market Share by Application
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

Geography Analysis

Metropolitan prefectures—Tokyo, Osaka, and Aichi—house 52% of scanners, driven by population density, tertiary centers, and stronger capital budgets. Urban facilities cycle equipment every 6–7 years, sustaining high-slice demand. In contrast, rural prefectures own aging fleets approaching a 10-year median age, prompting government grants for mobile units and AI retrofits rather than outright replacements.

Seismic risk shapes procurement in the Pacific coastal belt, where hospitals embed CT suites with earthquake-resistant mounts and maintain trailer-based backups parked off-site. Post-disaster deployment drills executed in 2024 demonstrated full diagnostic uptime within 48 hours of simulated infrastructure failure, validating policy investments.

Universal coverage guarantees identical scan-fee schedules nationwide, yet income disparities influence out-of-pocket extras such as expedited reporting. Tele-radiology networks connect Hokkaido’s rural clinics to Tokyo reading hubs, compressing turnaround from 48 hours to 6 hours and justifying new scanner acquisitions where local staffing is thin

Competitive Landscape

Four multinationals—Siemens Healthineers, GE HealthCare, Canon Medical Systems, and Philips—command significant 2024 revenue, indicating moderate concentration. Siemens leads in photon-counting patents, GE leverages radiopharmaceutical integration after buying Nihon Medi-Physics for USD 183 million, Canon benefits from domestic supply-chain goodwill, and Philips differentiates with iterative AI recon software.

Strategic cooperation is intensifying. Siemens and Sectra integrated spectral post-processing into mainstream PACS, eliminating workstation silos and speeding physician adoption. Canon and Olympus co-develop ultrasound-CT fusion imaging, signaling convergence plays that broaden modality ecosystems.

Start-ups focus on AI triage and radiation-dose tracking, often signing non-exclusive distribution deals with incumbents. The resulting value-chain interlock fosters service bundling—hardware, software, and isotope supply—creating sticky relationships that raise switching costs across the Japan computed tomography market.

Japan Computed Tomography Industry Leaders

  1. GE Healthcare

  2. Koninklijke Philips N.V.

  3. Canon Medical Systems

  4. Siemens Healthineers

  5. Fujifilm Holdings Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Japan Computed Tomography Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • March 2025: GE HealthCare completed acquisition of Nihon Medi-Physics for USD 183 million, integrating radiopharmaceuticals with CT workflows.
  • April 2023: Canon Inc. announced that Canon and the National Cancer Center Japan (NCC) have begun clinical research employing a next-generation X-ray CT system with photon-counting computed tomography (photon-counting CT, PCCT).

Table of Contents for Japan Computed Tomography Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapid adoption of photon-counting CT in academic centers
    • 4.2.2 Ageing population-driven oncologic imaging demand
    • 4.2.3 Disaster-preparedness funding for mobile CT fleets
    • 4.2.4 Reimbursement incentives for AI-enabled low-dose protocols
    • 4.2.5 Precision-oncology integration of CT radiomics
    • 4.2.6 OEM–AI start-up retro-fit collaborations lowering upgrade cost
  • 4.3 Market Restraints
    • 4.3.1 High capital outlay amid declining scan fees
    • 4.3.2 Shortage of radiologic technologists in rural prefectures
    • 4.3.3 Stricter national diagnostic reference levels on dose
    • 4.3.4 Slow PMDA approvals for next-gen detector technologies
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter’s Five Forces
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Suppliers
    • 4.7.3 Bargaining Power of Buyers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Industry Rivalry

5. Market Size & Growth Forecasts (Value)

  • 5.1 By Technology (Slice Count)
    • 5.1.1 Low-slice (<64)
    • 5.1.2 Mid-slice (64)
    • 5.1.3 High-slice (128–256)
  • 5.2 By Product Type
    • 5.2.1 Stationary CT Scanners
    • 5.2.2 Portable / Mobile CT Scanners
  • 5.3 By Application
    • 5.3.1 Oncology
    • 5.3.1.1 Lung Cancer Screening
    • 5.3.1.2 Head & Neck Oncology
    • 5.3.1.3 Colorectal Oncology
    • 5.3.1.4 Other Oncology
    • 5.3.2 Cardiology
    • 5.3.2.1 Coronary CT Angiography
    • 5.3.2.2 Calcium Scoring
    • 5.3.2.3 Structural Heart Disease
    • 5.3.3 Neurology
    • 5.3.3.1 Stroke Assessment
    • 5.3.3.2 Brain Trauma
    • 5.3.4 Vascular
    • 5.3.4.1 Peripheral Vascular Disease
    • 5.3.4.2 Pulmonary Angiography
    • 5.3.5 Musculoskeletal
    • 5.3.5.1 Orthopedic Trauma
    • 5.3.5.2 Sports Injuries
    • 5.3.6 Dental & Maxillofacial
    • 5.3.7 Trauma & Emergency
    • 5.3.8 Other Applications
  • 5.4 By End-User
    • 5.4.1 Hospitals
    • 5.4.1.1 Public Hospitals
    • 5.4.1.2 Private Hospitals
    • 5.4.2 Diagnostic Imaging Centers
    • 5.4.3 Dental Clinics
    • 5.4.4 Veterinary Clinics & Hospitals
    • 5.4.5 Academic & Research Institutes

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
    • 6.3.1 GE HealthCare Technologies Inc.
    • 6.3.2 Siemens Healthineers AG
    • 6.3.3 Canon Medical Systems Corp.
    • 6.3.4 Koninklijke Philips N.V.
    • 6.3.5 Shimadzu Corporation
    • 6.3.6 Fujifilm Healthcare Corp.
    • 6.3.7 Samsung Electronics Co., Ltd. (NeuroLogica)
    • 6.3.8 United Imaging Healthcare Co., Ltd.
    • 6.3.9 Mindray Bio-Medical Electronics Co., Ltd.
    • 6.3.10 Planmed Oy
    • 6.3.11 NeuroLogica Corp. (subsidiary of Samsung)
    • 6.3.12 Mediso Medical Imaging Systems Ltd.

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Japan Computed Tomography Market Report Scope

As per the report's scope, computed tomography (CT) is an imaging process that customizes special X-ray equipment to generate a sequence of exhaustive images or scans of areas inside the body. Japan Computed Tomography (CT) Market is Segmented by Type (Low Slice, Medium Slice, and High Slice), Application (Oncology, Neurology, Cardiovascular, Musculoskeletal, and Other Applications), End User (Hospitals, Diagnostic Centers, and Other End-Users). The report offers the value (in USD) for the above segments.

By Technology (Slice Count)
Low-slice (<64)
Mid-slice (64)
High-slice (128–256)
By Product Type
Stationary CT Scanners
Portable / Mobile CT Scanners
By Application
Oncology Lung Cancer Screening
Head & Neck Oncology
Colorectal Oncology
Other Oncology
Cardiology Coronary CT Angiography
Calcium Scoring
Structural Heart Disease
Neurology Stroke Assessment
Brain Trauma
Vascular Peripheral Vascular Disease
Pulmonary Angiography
Musculoskeletal Orthopedic Trauma
Sports Injuries
Dental & Maxillofacial
Trauma & Emergency
Other Applications
By End-User
Hospitals Public Hospitals
Private Hospitals
Diagnostic Imaging Centers
Dental Clinics
Veterinary Clinics & Hospitals
Academic & Research Institutes
By Technology (Slice Count) Low-slice (<64)
Mid-slice (64)
High-slice (128–256)
By Product Type Stationary CT Scanners
Portable / Mobile CT Scanners
By Application Oncology Lung Cancer Screening
Head & Neck Oncology
Colorectal Oncology
Other Oncology
Cardiology Coronary CT Angiography
Calcium Scoring
Structural Heart Disease
Neurology Stroke Assessment
Brain Trauma
Vascular Peripheral Vascular Disease
Pulmonary Angiography
Musculoskeletal Orthopedic Trauma
Sports Injuries
Dental & Maxillofacial
Trauma & Emergency
Other Applications
By End-User Hospitals Public Hospitals
Private Hospitals
Diagnostic Imaging Centers
Dental Clinics
Veterinary Clinics & Hospitals
Academic & Research Institutes
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

How big is the Japan Computed Tomography Market?

The Japan Computed Tomography Market size is expected to reach USD 0.39 billion in 2025 and grow at a CAGR of 5.87% to reach USD 0.52 billion by 2030.

What is the current Japan Computed Tomography Market size?

In 2025, the Japan Computed Tomography Market size is expected to reach USD 0.39 billion.

Who are the key players in Japan Computed Tomography Market?

GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems, Siemens Healthineers and Fujifilm Holdings Corporation are the major companies operating in the Japan Computed Tomography Market.

What years does this Japan Computed Tomography Market cover, and what was the market size in 2024?

In 2024, the Japan Computed Tomography Market size was estimated at USD 0.37 billion. The report covers the Japan Computed Tomography Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Japan Computed Tomography Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Page last updated on:

Japan Computed Tomography Report Snapshots